CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE Drug Patent Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Which patents cover Clindamycin Phosphate And Benzoyl Peroxide, and what generic alternatives are available?
Clindamycin Phosphate And Benzoyl Peroxide is a drug marketed by Actavis Labs Ut Inc, Encube, Glenmark Pharms, Mylan Pharms Inc, Padagis Israel, Taro, Taro Pharms, Tolmar, and Zydus Pharms. and is included in fifteen NDAs.
The generic ingredient in CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE is benzoyl peroxide; clindamycin phosphate. There are seventeen drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the benzoyl peroxide; clindamycin phosphate profile page.
Summary for CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE
| US Patents: | 0 |
| Applicants: | 9 |
| NDAs: | 15 |
| Finished Product Suppliers / Packagers: | 12 |
| Raw Ingredient (Bulk) Api Vendors: | 2 |
| Clinical Trials: | 12 |
| Patent Applications: | 17 |
| Formulation / Manufacturing: | see details |
| What excipients (inactive ingredients) are in CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE? | CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE excipients list |
| DailyMed Link: | CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE at DailyMed |
Recent Clinical Trials for CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Icahn School of Medicine at Mount Sinai | Phase 2 |
| Valeant Pharmaceuticals International, Inc. | Phase 2 |
| Bausch Health Americas, Inc. | Phase 2 |
See all CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE clinical trials
Pharmacology for CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE
| Drug Class | Lincosamide Antibacterial |
| Physiological Effect | Decreased Sebaceous Gland Activity Neuromuscular Blockade |
Anatomical Therapeutic Chemical (ATC) Classes for CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE
US Patents and Regulatory Information for CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE
CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE is protected by zero US patents and one FDA Regulatory Exclusivity.
FDA Regulatory Exclusivity protecting CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE
COMPETITIVE GENERIC THERAPY
Exclusivity Expiration: ⤷ Try a Trial
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Actavis Labs Ut Inc | CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE | benzoyl peroxide; clindamycin phosphate | GEL;TOPICAL | 205128-001 | Jun 19, 2015 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Padagis Israel | CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE | benzoyl peroxide; clindamycin phosphate | GEL;TOPICAL | 205397-001 | Sep 9, 2019 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Encube | CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE | benzoyl peroxide; clindamycin phosphate | GEL;TOPICAL | 212433-001 | Apr 28, 2021 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Taro | CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE | benzoyl peroxide; clindamycin phosphate | GEL;TOPICAL | 208776-001 | May 25, 2018 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
